Skip to main content

Table 2 Blocking step optimization

From: The localization of molecularly distinct microglia populations to Alzheimer's disease pathologies using QUIVER

Trial

A&B (drops/ml)

Device

Time (min)

FAB (ug/ml)

Device

Time (hr)

Area fraction (%)

Qualitative evaluation

1

0

–

–

20

S

1

34.305

++++ 

2

4

S

15

20

S

1

0.066

+

3

6

L

15

20

S

1

0.009

+

4

6

S

60

20

S

1

0.001

–

5

6

L

15

20

S

1

0.005

+

6

6

L

60

20

S

1

0.003

–

7

10

S

15

20

S

1

0.245

+++

8

6

S

60

0

–

–

46.380

++++

9

6

S

60

20

S

1

0.004

+

10

6

S

60

40

S

1

0.007

+

11

6

S

60

40

S

18

0.003

–

12

6

S

60

40

L

1

0.006

+

13

6

S

60

40

L

18

0.009

–

14

6

S

60

60

S

1

0.098

+

15

6

S

60

100

S

1

0.133

++

  1. During the incubations slides were in either Sequenza (S) or lockmailer (L) device. The HALO area fraction module was used to determine the % of stained tissue. An observe blind to the experimental conditions also rated the slides as robust residual staining (++++), some cells present throughout the tissue (+++), a few cells present in select regions (++), faint profiles for staining still observable (+), or no observable staining (–)